You are here

  • Home
  • Archive
  • Volume 64, Issue 11
  • Hypermethylation of ZNF545 is associated with poor prognosis in patients with early-stage hepatocellular carcinoma after thermal ablation

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Hypermethylation of ZNF545 is associated with poor prognosis in patients with early-stage hepatocellular carcinoma after thermal ablation
  1. Jie Yu1,
  2. Xin Li1,
  3. Qian Tao2,
  4. Xiao-ling Yu1,
  5. Zhi-gang Cheng1,
  6. Zhi-yu Han1,
  7. Mingzhou Guo3,
  8. Ping Liang1
  1. 1Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China
  2. 2Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  3. 3Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing, China
  1. Correspondence to Dr Ping Liang, Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China; liangping301{at}hotmail.com; Mingzhou Guo, M.D., Ph.D., Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing 100853, China; mzguo1@hotmail.com

https://doi.org/10.1136/gutjnl-2015-310258

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the article by Wang et al1 on zinc-finger protein 545 (ZNF545) acting as a tumour suppressor gene (TSG) in gastric cancer by inhibiting rRNA transcription and its methylation as a prognostic factor for early stages of gastric cancer. Inactivation of TSGs through promoter hypermethylation also plays an important role in progression of hepatocellular carcinoma (HCC).2–4 We wish to report the results of the expression profile and epigenetic regulation of ZNF545 in HCC, and its methylation role on early-stage HCC progression after thermal ablation.

    Our results showed reduced or loss of ZNF545 expression was found in seven human hepatic cancer cell lines, including SMMC7721, PRF/PCL-5, SK-hep1, HepG2, BEL7402, LAM3 and SNU449, by semiquantitative reverse transcription PCR. Expression of ZNF545 was detected in another cell of HBXF344. The methylation status of the ZNF545 promoter was examined by methylation-specific PCR (MSP). Complete methylation of the …

    View Full Text